Clinical Trial - Trial ChiCTR2200062210
Access comprehensive clinical trial information for ChiCTR2200062210 through Pure Global AI's free database. This Phase 1 trial is sponsored by General Hospital of Ningxia Medical University and is currently Recruiting. The study focuses on colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200062210
Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry โข ChiCTR2200062210
View on Chinese Clinical Trial RegistryUntitled Trial
Risk Factors for Postoperative Intensive Care Unit Admission after Colorectal Cancer Surgery.
Study Focus
Sponsor & Location
General Hospital of Ningxia Medical University
National Natural Science Foundation of China
China
Timeline & Enrollment
Phase 1
N/A
May 15, 2023
ICD-10 Classifications
Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon
Data Source
Chinese Clinical Trial Registry
ChiCTR2200062210
Non-Device Trial

